1,1-dichloroethene increases expression ISO Ahnak2 (Mus musculus) 6480464 vinylidene chloride results in increased expression of AHNAK2 mRNA CTD PMID:26682919 17beta-estradiol affects expression ISO AHNAK2 (Homo sapiens) 6480464 Estradiol affects the expression of AHNAK2 mRNA CTD PMID:14699072 17beta-estradiol increases expression ISO AHNAK2 (Homo sapiens) 6480464 Estradiol results in increased expression of AHNAK2 mRNA CTD PMID:31614463 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO AHNAK2 (Homo sapiens) 6480464 Tetrachlorodibenzodioxin affects the expression of AHNAK2 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO Ahnak2 (Mus musculus) 6480464 Tetrachlorodibenzodioxin affects the expression of AHNAK2 mRNA CTD PMID:21570461 2,4-dibromophenyl 2,4,5-tribromophenyl ether increases expression ISO AHNAK2 (Homo sapiens) 6480464 2 more ... CTD PMID:26705709 2-hydroxypropanoic acid increases expression ISO AHNAK2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AHNAK2 mRNA CTD PMID:30851411 3,3',4,4',5-pentachlorobiphenyl decreases expression EXP 6480464 3 more ... CTD PMID:32119087 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK2 mRNA more ... CTD PMID:28628672 4,4'-sulfonyldiphenol multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol S] results in decreased expression of AHNAK2 mRNA CTD PMID:28628672 4,4'-sulfonyldiphenol increases expression ISO AHNAK2 (Homo sapiens) 6480464 bisphenol S results in increased expression of AHNAK2 protein CTD PMID:34186270 4,4'-sulfonyldiphenol affects expression ISO AHNAK2 (Homo sapiens) 6480464 bisphenol S affects the expression of AHNAK2 protein CTD PMID:31945527 4-hydroxyphenyl retinamide decreases expression ISO Ahnak2 (Mus musculus) 6480464 Fenretinide results in decreased expression of AHNAK2 mRNA CTD PMID:28973697 5-aza-2'-deoxycytidine affects expression ISO AHNAK2 (Homo sapiens) 6480464 Decitabine affects the expression of AHNAK2 mRNA CTD PMID:23300844 acrolein multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AHNAK2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AHNAK2 mRNA CTD PMID:32699268 acrylamide decreases expression EXP 6480464 Acrylamide results in decreased expression of AHNAK2 mRNA CTD PMID:28959563 acrylamide decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Acrylamide results in decreased expression of AHNAK2 mRNA CTD PMID:32763439 aflatoxin B1 affects expression ISO AHNAK2 (Homo sapiens) 6480464 Aflatoxin B1 affects the expression of AHNAK2 protein CTD PMID:20106945 aflatoxin B1 increases expression ISO Ahnak2 (Mus musculus) 6480464 Aflatoxin B1 results in increased expression of AHNAK2 mRNA CTD PMID:19770486 alpha-pinene multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AHNAK2 mRNA and [Air Pollutants results in increased abundance of [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone]] which results in decreased expression of AHNAK2 mRNA CTD PMID:32699268 antirheumatic drug increases expression ISO AHNAK2 (Homo sapiens) 6480464 Antirheumatic Agents results in increased expression of AHNAK2 mRNA CTD PMID:24449571 aristolochic acid A decreases expression ISO AHNAK2 (Homo sapiens) 6480464 aristolochic acid I results in decreased expression of AHNAK2 protein CTD PMID:33212167 arsenite(3-) multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 arsenite inhibits the reaction [G3BP1 protein binds to AHNAK2 mRNA] CTD PMID:32406909 benzo[a]pyrene decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Benzo(a)pyrene results in decreased expression of AHNAK2 protein CTD PMID:32717239 benzo[a]pyrene increases expression ISO AHNAK2 (Homo sapiens) 6480464 Benzo(a)pyrene results in increased expression of AHNAK2 mRNA CTD PMID:32234424 benzo[a]pyrene affects methylation ISO AHNAK2 (Homo sapiens) 6480464 Benzo(a)pyrene affects the methylation of AHNAK2 promoter CTD PMID:27901495 benzo[a]pyrene increases expression ISO Ahnak2 (Mus musculus) 6480464 Benzo(a)pyrene results in increased expression of AHNAK2 mRNA CTD PMID:22228805 bis(2-ethylhexyl) phthalate increases expression ISO AHNAK2 (Homo sapiens) 6480464 Diethylhexyl Phthalate results in increased expression of AHNAK2 mRNA CTD PMID:31163220 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of AHNAK2 mRNA CTD PMID:25181051 bisphenol A affects expression ISO AHNAK2 (Homo sapiens) 6480464 bisphenol A affects the expression of AHNAK2 protein CTD PMID:34186270 bisphenol A increases expression ISO Ahnak2 (Mus musculus) 6480464 bisphenol A results in increased expression of AHNAK2 mRNA CTD PMID:35479511 bisphenol A multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK2 mRNA CTD PMID:28628672 bisphenol A increases expression ISO AHNAK2 (Homo sapiens) 6480464 bisphenol A results in increased expression of AHNAK2 mRNA and bisphenol A results in increased expression of AHNAK2 protein CTD PMID:27685785 more ... Bisphenol B increases expression ISO AHNAK2 (Homo sapiens) 6480464 bisphenol B results in increased expression of AHNAK2 protein CTD PMID:34186270 bisphenol F multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in decreased expression of AHNAK2 mRNA CTD PMID:28628672 buserelin multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [Buserelin co-treated with CGB3 protein] results in increased expression of AHNAK2 mRNA CTD PMID:19955106 butanal increases expression ISO AHNAK2 (Homo sapiens) 6480464 butyraldehyde results in increased expression of AHNAK2 mRNA CTD PMID:26079696 cadmium dichloride decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Cadmium Chloride results in decreased expression of AHNAK2 mRNA CTD PMID:26472689 carbamazepine affects expression ISO AHNAK2 (Homo sapiens) 6480464 Carbamazepine affects the expression of AHNAK2 mRNA CTD PMID:25979313 chloropicrin affects expression ISO AHNAK2 (Homo sapiens) 6480464 chloropicrin affects the expression of AHNAK2 mRNA CTD PMID:26352163 cisplatin affects expression ISO AHNAK2 (Homo sapiens) 6480464 Cisplatin affects the expression of AHNAK2 mRNA CTD PMID:23300844 cobalt dichloride decreases expression ISO AHNAK2 (Homo sapiens) 6480464 cobaltous chloride results in decreased expression of AHNAK2 mRNA CTD PMID:19320972 Cuprizon decreases expression EXP 6480464 Cuprizone results in decreased expression of AHNAK2 mRNA CTD PMID:26577399 cyclosporin A decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Cyclosporine results in decreased expression of AHNAK2 mRNA CTD PMID:27989131 dexamethasone multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK2 mRNA more ... CTD PMID:28628672 diallyl trisulfide increases expression ISO AHNAK2 (Homo sapiens) 6480464 diallyl trisulfide results in increased expression of AHNAK2 mRNA CTD PMID:34995734 dimethylarsinous acid decreases expression ISO AHNAK2 (Homo sapiens) 6480464 dimethylarsinous acid results in decreased expression of AHNAK2 mRNA CTD PMID:23487506 dorsomorphin multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 doxorubicin multiple interactions ISO Ahnak2 (Mus musculus) 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of AHNAK2 mRNA CTD PMID:21040762 doxorubicin increases expression ISO AHNAK2 (Homo sapiens) 6480464 Doxorubicin results in increased expression of AHNAK2 mRNA CTD PMID:30031762 doxorubicin affects expression ISO AHNAK2 (Homo sapiens) 6480464 Doxorubicin affects the expression of AHNAK2 mRNA and Doxorubicin affects the expression of AHNAK2 protein CTD PMID:29385562 and PMID:29803840 entinostat increases expression ISO AHNAK2 (Homo sapiens) 6480464 entinostat results in increased expression of AHNAK2 mRNA CTD PMID:26272509 entinostat multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AHNAK2 mRNA CTD PMID:27188386 ferric oxide increases expression ISO Ahnak2 (Mus musculus) 6480464 ferric oxide analog results in increased expression of AHNAK2 mRNA CTD PMID:25086211 FR900359 affects phosphorylation ISO AHNAK2 (Homo sapiens) 6480464 FR900359 affects the phosphorylation of AHNAK2 protein CTD PMID:37730182 glyphosate increases expression ISO Ahnak2 (Mus musculus) 6480464 Glyphosate results in increased expression of AHNAK2 mRNA CTD PMID:35897073 indometacin multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol A] results in decreased expression of AHNAK2 mRNA more ... CTD PMID:28628672 isobutanol multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AHNAK2 mRNA CTD PMID:29432896 isoprenaline increases expression ISO Ahnak2 (Mus musculus) 6480464 Isoproterenol results in increased expression of AHNAK2 mRNA CTD PMID:20003209 ivermectin decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Ivermectin results in decreased expression of AHNAK2 protein CTD PMID:32959892 manganese(II) chloride increases expression EXP 6480464 manganese chloride results in increased expression of AHNAK2 mRNA CTD PMID:28801915 mercury dichloride decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Mercuric Chloride results in decreased expression of AHNAK2 mRNA CTD PMID:27188386 N-methyl-4-phenylpyridinium increases expression ISO AHNAK2 (Homo sapiens) 6480464 1-Methyl-4-phenylpyridinium results in increased expression of AHNAK2 mRNA CTD PMID:24810058 nickel sulfate increases expression ISO AHNAK2 (Homo sapiens) 6480464 nickel sulfate results in increased expression of AHNAK2 mRNA CTD PMID:18651567 ozone multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [Acrolein co-treated with methacrylaldehyde co-treated with alpha-pinene co-treated with Ozone] results in decreased expression of AHNAK2 mRNA more ... CTD PMID:32699268 pentanal increases expression ISO AHNAK2 (Homo sapiens) 6480464 pentanal results in increased expression of AHNAK2 mRNA CTD PMID:26079696 perfluorohexanesulfonic acid increases expression ISO Ahnak2 (Mus musculus) 6480464 perfluorohexanesulfonic acid results in increased expression of AHNAK2 mRNA CTD PMID:37995155 phenylmercury acetate multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [NOG protein co-treated with Phenylmercuric Acetate co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AHNAK2 mRNA CTD PMID:27188386 potassium chromate decreases expression ISO AHNAK2 (Homo sapiens) 6480464 potassium chromate(VI) results in decreased expression of AHNAK2 mRNA CTD PMID:22714537 propanal increases expression ISO AHNAK2 (Homo sapiens) 6480464 propionaldehyde results in increased expression of AHNAK2 mRNA CTD PMID:26079696 quercitrin increases expression ISO AHNAK2 (Homo sapiens) 6480464 quercitrin results in increased expression of AHNAK2 mRNA CTD PMID:25193878 rac-lactic acid increases expression ISO AHNAK2 (Homo sapiens) 6480464 Lactic Acid results in increased expression of AHNAK2 mRNA CTD PMID:30851411 SB 431542 multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [LDN 193189 co-treated with 4-(5-benzo(1 more ... CTD PMID:27188386 and PMID:37664457 silicon dioxide increases expression ISO AHNAK2 (Homo sapiens) 6480464 Silicon Dioxide analog results in increased expression of AHNAK2 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO Ahnak2 (Mus musculus) 6480464 Silicon Dioxide results in increased expression of AHNAK2 mRNA CTD PMID:29203145 sodium arsenite multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 sodium arsenite promotes the reaction [AHNAK2 protein binds to CAPRIN1 protein] CTD PMID:33939924 succimer multiple interactions ISO Ahnak2 (Mus musculus) 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of AHNAK2 mRNA CTD PMID:21641980 sunitinib increases expression ISO AHNAK2 (Homo sapiens) 6480464 Sunitinib results in increased expression of AHNAK2 mRNA CTD PMID:31533062 temozolomide decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Temozolomide results in decreased expression of AHNAK2 mRNA CTD PMID:31758290 tetraphene decreases expression ISO Ahnak2 (Mus musculus) 6480464 benz(a)anthracene results in decreased expression of AHNAK2 mRNA CTD PMID:26377693 thimerosal decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Thimerosal results in decreased expression of AHNAK2 mRNA CTD PMID:27188386 trichostatin A decreases expression ISO AHNAK2 (Homo sapiens) 6480464 trichostatin A results in decreased expression of AHNAK2 mRNA CTD PMID:27188386 tris(2-butoxyethyl) phosphate affects expression ISO AHNAK2 (Homo sapiens) 6480464 tris(2-butoxyethyl) phosphate affects the expression of AHNAK2 mRNA CTD PMID:29024780 urethane increases expression ISO AHNAK2 (Homo sapiens) 6480464 Urethane results in increased expression of AHNAK2 mRNA CTD PMID:28818685 valproic acid decreases expression ISO AHNAK2 (Homo sapiens) 6480464 Valproic Acid results in decreased expression of AHNAK2 mRNA CTD PMID:29154799 valproic acid increases methylation ISO AHNAK2 (Homo sapiens) 6480464 Valproic Acid results in increased methylation of AHNAK2 gene CTD PMID:29154799 valproic acid affects expression ISO AHNAK2 (Homo sapiens) 6480464 Valproic Acid affects the expression of AHNAK2 mRNA CTD PMID:25979313 valproic acid increases expression ISO AHNAK2 (Homo sapiens) 6480464 Valproic Acid results in increased expression of AHNAK2 mRNA CTD PMID:23179753 more ... valproic acid multiple interactions ISO AHNAK2 (Homo sapiens) 6480464 [NOG protein co-treated with Valproic Acid co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in increased expression of AHNAK2 mRNA CTD PMID:27188386 vitamin E increases expression ISO AHNAK2 (Homo sapiens) 6480464 Vitamin E results in increased expression of AHNAK2 mRNA CTD PMID:19244175 vorinostat decreases expression ISO AHNAK2 (Homo sapiens) 6480464 vorinostat results in decreased expression of AHNAK2 mRNA CTD PMID:18769122 and PMID:27188386 zoledronic acid decreases expression ISO AHNAK2 (Homo sapiens) 6480464 zoledronic acid results in decreased expression of AHNAK2 mRNA CTD PMID:24714768